Trelleborg to speed up new product development process

Trelleborg’s Healthcare & Medical experts will announce its latest capability to help healthcare and medical customers expedite their new product development process at MD&M West in Anaheim, California, August 10–12, 2021. 

This new offering will help minimize production costs, quicken development time, and ensure superior-quality products.  

Linda Muroski, President of Trelleborg Global Healthcare & Medical and Marketing Americas, says: “This service will accelerate our customers’ time-to-market and help them achieve their mission of improving patients’ lives.”

Visitors to the booth (Hall D, Booth 2601) will also see an extensive selection of Trelleborg’s specialty extruded tubing and hose products. Tubes are available in a full range of sizes and are custom designed with customers to meet their individual application needs. 

Andrew Gaillard, Global Director of Trelleborg Healthcare & Medical, says: “We engineer novel extrusion solutions for our customers’ specific tube and hosing applications. Examples include multi-lumen, silicone foam extrusions, and kink-resistant tubing for a variety of critical applications such as pacemaker and neuromodulation leads and urological implants. Additionally, Trelleborg’s GeoTrans technology enables the production of extrusion profiles that can change throughout the length of the extrusion, supporting unique, customer-specific designs.”

Trelleborg will also showcase its molded parts that are often used in implantable healthcare and medical devices. Using in-house precision tooling and expertise, Trelleborg creates custom silicone and thermoplastic molded parts with tight tolerances, while the need for rapid product development is met with quick turnaround prototypes. In addition, attendees will be able to see Trelleborg’s advancements in multicomponent and micromolding capabilities. 

Gaillard says: “One of our most well accepted capabilities is the combination of Liquid Silicone Rubber (LSR) with plastics. Commonly referred to as 2C or 2-shot, multicomponent injection molding allows our LSR experts to employ highly sophisticated tool and process engineering to develop innovative solutions that combine two or more individual materials into one fully bonded, robust component.”

Finally, attendees at MD&M West will see Trelleborg’s silicone sheeting and drug delivery capabilities. These highlight the continued evolution of technologies enabling the development of novel solutions for patient care. 

“In recent years, we’ve seen a spike in demand from our customer-partners for devices that incorporate an active pharmaceutical ingredient for targeted delivery of a therapy. Whether challenged with a wound-care application that requires wafer-thin silicone gel films with a drug element incorporated, or an innovative approach to cancer treatment with unique manufacturing challenges, our engineering teams are consistently eager to partner with customers to help solve interesting and complex problems,” concludes Gaillard.